We have become remarkably good at describing the gut microbiome.
With modern metagenomics, we can catalogue thousands of microbial species, compare their abundance between health and disease, and reconstruct the metabolic pathways they encode. Yet one deceptively simple question is still surprisingly difficult to answer: why do some microbes manage to stay?
For a microorganism to influence its host, it first has to survive gastrointestinal transit, compete for nutrients, tolerate host-derived stresses, interact with neighbouring microbes and establish a stable niche. Colonization is therefore not a side issue in microbiome biology. It is the prerequisite for almost everything that comes afterwards.
This idea motivated our study, recently published in Nature Communications. Rather than asking only which microbes are present in the human gut, we wanted to ask what functional traits may help them establish residence — and whether these traits are reorganized when the intestinal environment is altered by disease.
From individual genes to a microbiome-wide map
Much of what we know about microbial colonization has come from elegant experimental studies of individual pathogens or model commensals. Transposon screens and other functional approaches have identified genes involved in nutrient acquisition, stress tolerance, adhesion, signalling and niche adaptation.
But there is an obvious limitation: most gut microbes are difficult to culture, and even fewer are genetically tractable.
This creates a scale problem. Colonization is fundamentally a community-wide ecological process, yet our mechanistic knowledge has largely come from a small collection of experimentally accessible organisms.
We therefore asked whether colonization-associated genes could be viewed at the scale of the whole human gut microbiome.
Using 79 curated colonization factor families, or CFs, we searched nearly 290,000 microbial genomes from the human gut. The scale of the resulting map surprised us. We identified more than seven million CF homologues across 4,716 species, and 99.9% of the surveyed genomes encoded at least one colonization factor.
Colonization-associated functions, in other words, are almost universal among human gut microbes.
But they are not organized uniformly.
Different microbial lineages carried distinct combinations of CFs, revealing a functional layer that was broadly shared across the microbiome yet differentiated according to lineage. This was an important distinction for us. The atlas was not simply another list of microbial genes. It suggested that gut microbes may solve the common problem of colonization in different ways.
Different ways of making a living in the gut
When we examined how CF families were combined across microbial species, three broad patterns emerged.
One group was enriched for functions related to nutrient utilization and metabolic versatility. A second emphasized stress resistance, redox homeostasis and environmental adaptation. A third was characterized by carbohydrate transport, nutrient sensing and microbial communication, including phosphotransferase systems and quorum-sensing-related functions.
We cautiously refer to these as putative colonization strategies: metabolism-centric, stress-resistance-oriented and communication-mediated.
These categories should not be interpreted as rigid ecological identities. A bacterium obviously does not rely on a single programme to colonize the gut. What interested us was that combinations of colonization-associated genes were not random. They tracked broader genome-wide functional organization and showed strong preferences across microbial lineages.
This suggested a useful way of thinking about gut microbes: not only by who they are, but also by the kinds of ecological problems they appear equipped to solve.
Some lineages may be especially good at exploiting nutrient niches. Others may be better suited to surviving oxidative or host-derived stress. Still others may depend more strongly on environmental sensing, carbohydrate uptake or microbial communication.
The gut is one ecosystem, but there may be many ways to persist within it.
What happens when the ecosystem becomes inflamed?
Once we had this framework, the next question was obvious.
If colonization factors reflect microbial adaptation to the gut environment, what happens when that environment changes?
Inflammatory bowel disease offered a particularly relevant setting. IBD is associated with major changes in microbial composition, nutrient availability, redox conditions and host immune pressure. We already know that certain commensals decline and inflammation-associated organisms expand. But these taxonomic changes do not necessarily tell us which functional traits are being selected by the inflamed gut.
We therefore analysed 3,666 metagenomic and metatranscriptomic samples from ten independent IBD cohorts.
One of the most interesting findings was what we did not see.
The colonization-factor landscape did not collapse globally in IBD. Instead, it appeared relatively conserved, with disease-associated dysbiosis reflected in the selective remodeling of particular CF families and their microbial carriers.
This distinction became central to how we interpreted the study.
IBD may not simply destabilize every aspect of microbial colonization. Rather, inflammation appears to change the ecological filter. Certain colonization functions become more represented, others less so, and these shifts can be traced back to the microbial lineages that carry them.
Several phosphotransferase system-related CFs repeatedly emerged across cohorts. These systems are involved not only in sugar uptake, but also in nutrient sensing and broader metabolic regulation. Their recurrence is intriguing because the inflamed gut is a profoundly altered nutritional and physicochemical environment.
We cannot yet say that these genes directly drive bacterial fitness in IBD. The present evidence is associative, and functional validation will be essential. But the pattern gives us a more specific question to test experimentally: which colonization traits allow particular microbes to expand when the intestinal environment becomes inflamed?
That is a different question from simply asking which bacteria are enriched in disease.
The challenge of extracting mechanism from big data
This study is entirely computational, which created a different set of challenges from our previous experimental work.
With large microbiome datasets, it is easy to find patterns. The harder task is deciding which patterns are biologically meaningful.
One concern we repeatedly returned to was whether CF profiles were simply rediscovering taxonomy. Another was whether disease-associated CF signals were genuinely informative or merely reflected the abundance of the species carrying them. We therefore used matched random protein-family backgrounds, phylogenetic analyses and carrier-resolved approaches to test how much of the signal could be explained by broader genomic structure.
These analyses made the conclusions more nuanced.
CF repertoires are clearly associated with microbial lineages, but they are not independent of taxonomy. Similarly, CF-based classifiers do not outperform high-dimensional species-level profiles — nor should they be expected to. Taxonomic profiles retain far more information.
The value of CF profiling lies somewhere else.
It compresses a complex microbial community into a relatively small number of biologically interpretable colonization-related functions. In our IBD analyses, much of the disease-associated signal could ultimately be represented by a compact 13-CF-family panel.
For us, that was not primarily a diagnostic result. It was a demonstration that the enormous complexity of microbiome dysbiosis can sometimes be projected onto a smaller number of ecological functions that are easier to interpret and, importantly, easier to follow up experimentally.
From “who is there?” to “why can they stay?”
This work also represents an important expansion of how our laboratory approaches microbiome biology.
In our recent experimental studies, we focused on defined microbial strains, metabolites and host pathways — for example, how microbial tryptophan metabolism can promote intestinal epithelial regeneration through specific stem-cell programmes.
Those studies asked what a particular microbe or metabolite does to the host.
The present study begins one step earlier.
Before a microbe can produce a metabolite, signal to a stem cell or influence immunity, it must first occupy the ecosystem. So here we asked a more ecological question: what allows a microbe to establish itself in the first place?
These two scales are complementary.
Large-scale genomics can reveal recurrent ecological patterns and help prioritize candidate functions. Experimental models can then test whether those functions actually determine colonization, competition and host interaction. We see this as a useful way forward: moving from data-driven ecological discovery to mechanistic validation, and then back again.
The same framework may also be valuable beyond the human gut.
Livestock species such as pigs experience dramatic shifts in intestinal ecology during weaning, dietary transition, stress and enteric infection. These settings also involve altered nutrient landscapes, inflammatory pressure and rapid microbial turnover. Understanding which colonization traits allow beneficial microbes to persist — or opportunistic organisms to expand — could provide a functional bridge between microbiome surveys and intervention strategies in animal health.
Looking ahead
Our atlas is not a final catalogue of microbial colonization.
Reference genome collections are still incomplete, strain-level variation remains underrepresented, and the disease associations we identified require direct experimental validation. Metatranscriptomic data are also much more limited than metagenomic datasets, leaving open the question of when colonization potential is actually deployed in vivo.
But these limitations point directly to the next experiments.
Can specific CFs predict competitive fitness in defined microbial communities? Do the same colonization strategies operate across host species? Which functions become advantageous during inflammation, infection or dietary change? And can these ecological traits eventually be manipulated to favour beneficial colonizers over disease-associated microbes?
For us, the most important contribution of this study is not the seven million genes in the atlas.
It is the shift in perspective.
Microbiome research has spent years asking who is there and who changes in disease. Colonization biology asks another question: why are they able to be there at all?
By adding this functional layer, we hope to move one step closer to understanding not just how microbial communities change, but the ecological rules that determine who stays, who expands and who disappears.